Who we are
Owkin uses artificial intelligence (AI) to find the right treatment for every patient.
Since 1815, Erlangen University hospital has operated at the frontier of healthcare innovation.
The CHUV, since 2019 ranked among the best 15 hospitals worldwide by Newsweek, is one of the five Swiss universities.
Leading Cancer Center in Europe, ranked third best oncology hospital in the world, according to Newsweek in 2023.
The Charité is the medical faculty of the Humboldt University and the Free University of Berlin.
A top-ranked, public institution in the U.S.
MOSAIC is an initiative of academic, technology and AI partners formed to:
Generate spatial omics data
The MOSAIC initiative will create a multimodal dataset with spatial transcriptomes from 7,000 patients in 7 cancer types. This is the largest spatial omics atlas to date.
Develop and apply AI to spatial omics data
Data scientists will apply state-of-the-art interpretable AI to analyze large-scale multimodal patient data to drive cancer research forward.
Create standards for spatial omics
Common scientific governance will ensure full compliance of the MOSAIC project with regulations in order to set future standards for spatial omics research together.
MOSAIC researchers will harmonize data capture and standardize sample preparation across all tumor types.
How is MOSAIC structured?
MOSAIC is a large-scale initiative that combines patient samples and technologies from multiple institutions, hospitals and technology partners, who are joining forces with Owkin to create the largest multimodal, spatial omics atlas in cancer.
Contact us to learn how to get involved.
Founding Partners
Owkin